FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

A drug with the potential to drastically curb the HIV epidemic just cleared its first regulatory hurdle. On Wednesday, the Food and Drug Administration approved lenacapavir for the prevention of HIV.

The U.S. FDA approved Gilead Sciences' lenacapavir injection to prevent HIV in adults and adolescents. Marketed as Yeztugo, ...

A United Nations agency has urged the pharmaceutical company Gilead Sciences to lower the price of the long acting antiviral treatment lenacapavir following the US Food and Drug Administration (FDA)’s ...

The approval of Lenacapavir – a twice-yearly antiviral HIV-preventing medication marketed under the brand name Yeztugo – by the US Food and Drug Administration (FDA), has been welcomed by the global ...